DFCM
CGON icon

Dark Forest Capital Management’s CG Oncology CGON Stock Holding History

Dark Forest Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,895
Closed -$369K – 841
2025
Q4 		$369K Buy
+8,895
New +$368K 0.02% 858
2024
Q4 		– Sell
-22,596
Closed -$853K – 981
2024
Q3 		$853K Buy
+22,596
New +$792K 0.11% 203

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dark Forest Capital Management's CGON Position: Q1 2026 in Review

Dark Forest Capital Management sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 8,895 shares — an estimated $369K sold.

Dark Forest Capital Management first reported a position in CGON in Q3 2024 and held it in 2 quarters. The position peaked at $853K in Q3 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Dark Forest Capital Management reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 8,895 CG Oncology shares in Q1 2026, an estimated $369K.
  • Dark Forest Capital Management first reported a position in CG Oncology in Q3 2024 and held it in 2 quarters.
  • Dark Forest Capital Management's CG Oncology position peaked at $853K in Q3 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.